al. Kinetics of acetaminophen absorptionand gastric emptying in man. Clin Phar- macol Ther.  1978; 24:420-31. 23. Fineman MS, Bicsak TA, Shen LZ et al. Effect on glycemic control of exenatide(synthetic exendin-4) additive to existingmetformin and/or sulfonylurea treat-ment in patients with type 2 diabetes. Di- abetes Care.  2003; 26:2370-7. 24. Mallinckrodt CH, Clark SW, Carroll RJ et al. Assessing response profiles from in-complete longitudinal clinical trial dataunder regulatory considerations. J Bio- pharm Stat .  2003; 13:179-90. 25. Parkes D, Jodka C, Smith P et al. Pharma- cokinetic actions of exendin-4 in the rat:comparison with glucagon-like peptide-1. Drug Dev Res.  2001; 53:260-7. 26. Kieffer TJ, McIntosh CH, Pederson RA. Degradation of glucose-dependent in-sulinotropic polypeptide and truncatedglucagon-like peptide 1 in vitro and invivo by dipeptidyl peptidase IV. Endocri- nology.  1995; 136:3585-96. 27. Deacon CF, Nauck MA, Toft-Nielsen M